Understanding and Managing Adverse Events in Patients Treated with Tepezza
Tepezza (teprotumumab) has emerged as a groundbreaking treatment for thyroid eye disease, offering hope to patients with this rare condition. Approved by the FDA in January 2020, Tepezza has shown […]
Understanding and Managing Adverse Events in Patients Treated with Tepezza Read More ยป